News

News GlobeNewswire NKGen Biotech Chairman & CEO Paul Y. Song, M.D., Personally Invests $2.65 Million Cash to Accelerate Phase 2 Clinical Trial and Fulfill Financial Reporting Obligations ...
expand Doug Edgeton, CEO of the North Carolina Biotechnology Center Mehmet Demirci By Zac Ezzone – Reporter, Triad Business Journal May 22, 2025 Preview this article 1 min ...
Perhaps it’s just the summer slowdown, but it’s been a light month for executive hires in the pharma and biotech world.